Manufacturing roundup: Thermo Fisher opens facility in Singapore; Forge Biologics to partner with consortium to manufacture AAVs
Thermo Fisher Scientific opened the doors to a new sterile drug facility in Singapore.
The new facility, which was set up with assistance from the Singapore Economic Development Board, aims to provide vaccine fill-finish capabilities and other development and manufacturing services. It will also have a fill-finish line for small and large molecules.
Thermo Fisher already has a presence in Singapore with several laboratories that focus on bioprocessing, life science and analytical services.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters